DR. BASIL RIGAS, M.D.
Osteopathic Medicine at Technology Dr, Strongs Neck, NY
License number
New York 167689
Category
Osteopathic Medicine
Type
Gastroenterology
Address
Address
2
3 Technology Dr, Strongs Neck, NY 11733
PO Box 1559, Stonybrook, NY 11790
PO Box 1559, Stonybrook, NY 11790
Phone
(631) 444-5220
Organization information
See more information about BASIL RIGAS at bizstanding.comBasil Rigas MD
Gcrc 12, Stonybrook, NY 11794
Industry:
Internist
Phone:
(631) 444-5220 (Phone)
Basil Rigas
Professional information
Basil Rigas, East Setauket NY
Specialties:
Gastroenterologist
Address:
3 Technology Dr, East Setauket, NY 11733
Stony Brk, Stony Brook, NY 11794
Stony Brk, Stony Brook, NY 11794
Education:
University of Athens, School of Health Sciences - Doctor of Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Gastroenterology (Internal Medicine)
Treatment Of Inflammatory Bowel Diseases Using A Tripeptide
US Patent:
2013026, Oct 3, 2013
Filed:
Aug 31, 2011
Appl. No.:
13/820051
Inventors:
Ting Nie - Selden NY, US
Basil Rigas - Old Field NY, US
Nengtai Ouyang - Setauket NY, US
Basil Rigas - Old Field NY, US
Nengtai Ouyang - Setauket NY, US
Assignee:
THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK - Albany NY
International Classification:
C07K 5/083, C07K 7/06, C07K 7/64
US Classification:
514 211, 530321, 514 219, 514 216, 530331, 530329
Abstract:
The present invention provides peptides and peptide conjugates for treating inflammatory bowel diseases, including ulcerative colitis and Crohn's disease. The peptides are derived from annexin-1, can be acetylated or conjugated to fatty acids, may be linear or cyclic, and may comprise D amino acids. Pharmaceutical compositions and methods of use are also disclosed.
Dr. Basil Rigas, East Setauket NY - MD (Doctor of Medicine)
Specialties:
Gastroenterology
Address:
University Gastroenterology Hep
3 Technology Dr STE 700, East Setauket 11733
(631) 444-5220 (Phone)
3 Technology Dr STE 700, East Setauket 11733
(631) 444-5220 (Phone)
Certifications:
Gastroenterology, 1985, Internal Medicine, 1982
Awards:
Healthgrades Honor Roll
Languages:
English, Greek
Hospitals:
University Gastroenterology Hep
3 Technology Dr STE 700, East Setauket 11733
Stony Brook University Hospital
101 Nicolls Rd, Stony Brook 11794
3 Technology Dr STE 700, East Setauket 11733
Stony Brook University Hospital
101 Nicolls Rd, Stony Brook 11794
Education:
Medical School
University Of Athens, School Of Health Sciences
Graduated: 1972
Memorial Hospital Of Rhode Island
Rhode Island Hospital Lifespan
University Of Athens, School Of Health Sciences
Graduated: 1972
Memorial Hospital Of Rhode Island
Rhode Island Hospital Lifespan
Peptide Compositions And Methods Of Use
US Patent:
2011017, Jul 14, 2011
Filed:
Jan 27, 2011
Appl. No.:
13/015456
Inventors:
Basil Rigas - Old Field NY, US
Yu Sun - Port Jefferson NY, US
Yu Sun - Port Jefferson NY, US
Assignee:
The Research Foundation of State University of New York - Stony Brook NY
International Classification:
A61K 9/127, C07K 14/00, A61K 38/04, A61K 39/395, A61P 35/00, A61P 25/00, A61P 9/00, A61P 19/02, A61P 25/28
US Classification:
424450, 530324, 530325, 530326, 514 213, 514 214, 4241301, 514 193, 514 194, 514 177, 514 164, 514 166, 514 178, 514 168
Abstract:
The present invention provides isolated peptides with at least two cysteine residues capable of forming one or more disulfide bonds. Pharmaceutical compositions comprising the isolated peptides of the present invention are also provided. The invention also provides methods for inhibiting, preventing or improving the pathological or clinical manifestations of cancer or an inflammatory disease or disorder in a subject, comprising administering a peptide of the invention.
Inhibitors Of Nf-Kb Activity
US Patent:
2012000, Jan 5, 2012
Filed:
Mar 28, 2008
Appl. No.:
12/593550
Inventors:
Zhiquan Zhang - Durham NC, US
Basil Rigas - Old Field NY, US
Basil Rigas - Old Field NY, US
Assignee:
THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK - Albany NY
International Classification:
A61K 38/17, C12N 15/63, G01N 33/566, G06G 7/58, A61P 25/00, A61K 31/7105, A61P 29/00, C12N 5/071, A61P 35/00
US Classification:
514 122, 435375, 4353201, 436501, 435 792, 514 192, 514 183, 514 44 R, 703 11
Abstract:
The present invention provides a method for inhibiting NF-κB activity in a subject, the method comprising providing an agent capable of inducing expression of annexin 1, whereby said agent induces expression of annexin 1 and whereby said induced expression of annexin 1 inhibits NF-κB activity. Also provided are annexin 1 mimetics capable of binding to NF-κB and pharmaceutical compositions of such inducing and mimetic agents.
Detection Of H. Pylori Utilizing Unlabeled Urea
US Patent:
2012003, Feb 9, 2012
Filed:
Sep 17, 2008
Appl. No.:
12/678654
Inventors:
Basil Rigas - Old Field NY, US
Anastasia Rigas - Old Field NY, US
Krithika Kalyanasundaram - Longmont CO, US
Anastasia Rigas - Old Field NY, US
Krithika Kalyanasundaram - Longmont CO, US
International Classification:
C12Q 1/04, C01G 41/02, B82Y 30/00
US Classification:
435 34, 423606, 977762, 977948
Abstract:
Disclosed is a method and device for detection of in breath emissions utilizing an unlabelled urea, in which a patient ingests a safe quantity of unlabelled urea. After ingestion, expired breath of the patient is analyzed for ammonia, with a detection based on levels of ammonia lower than 50 parts per billion to 500 ppm to detect
Phospho-Ester Derivatives And Uses Thereof
US Patent:
2013022, Aug 29, 2013
Filed:
Feb 27, 2013
Appl. No.:
13/779382
Inventors:
Basil RIGAS - Setauket NY, US
International Classification:
A61K 31/661, A61K 45/06, A61K 31/192, A61K 31/675, A61K 31/664
US Classification:
514 91, 514109, 514119, 514120, 514569
Abstract:
Phospho-ester compounds and pharmaceutical compositions thereof administered by the respiratory and other routes for the prevention and/or treatment of lung and brain cancer and precancerous conditions thereof, for the treatment of pain, for the treatment of skin disorders, for treating and/or preventing inflammation-related diseases, and for the treatment and prevention of cancer.
Detection Of Cancer Markers
US Patent:
2009031, Dec 24, 2009
Filed:
Apr 25, 2008
Appl. No.:
12/109836
Inventors:
Kalle LEVON - Brooklyn NY, US
Miriam RAFAILOVICH - Stony Brook NY, US
Basil RIGAS - Old Field NY, US
Yantian Wang - Port Jefferson Station NY, US
Miriam RAFAILOVICH - Stony Brook NY, US
Basil RIGAS - Old Field NY, US
Yantian Wang - Port Jefferson Station NY, US
International Classification:
A61B 5/1468
US Classification:
600345
Abstract:
The present invention relates to combining surface molecular imprinting (SMI) with the production of self-assembled monolayers (SAM) of hydroxyl alkanethiolate molecules on gold coated chip surfaces. In this technique, the sensing element is placed on the transducer and the whole assembly can then be miniaturized and integrated into a smart chip. These sensors can detect, nanomolar quantities of complex biomolecules.
Anti-Inflammatory Compounds And Uses Thereof
US Patent:
8236820, Aug 7, 2012
Filed:
Aug 11, 2008
Appl. No.:
12/189500
Inventors:
Basil Rigas - Setauket NY, US
International Classification:
A01N 47/00
US Classification:
514320, 514107, 514110, 514124, 558160, 558196, 558197, 558198, 558 86
Abstract:
Compounds of the general formula.
Anti-Inflammatory Compounds And Uses Thereof
US Patent:
2012031, Dec 13, 2012
Filed:
Jul 27, 2012
Appl. No.:
13/559884
Inventors:
Basil RIGAS - Setauket NY, US
International Classification:
A61K 31/661, C07F 9/6574, A61K 31/6615, A61P 29/00, A61P 9/00, A61P 25/28, A61P 25/00, A61P 37/00, A61P 35/00, A61P 9/12, A61P 19/04, A61P 11/08, A61P 11/02, A61P 35/02, C07F 9/09
US Classification:
514107, 558198, 514121, 558197, 514124, 514120, 558208, 514144, 558179, 558 86, 514110, 558160
Abstract:
Compounds of the general formulaare disclosed with activity towards treating diseases related to inflammation, such as cancer, neurodegenerative and cardiovascular diseases. Pharmaceutical compositions and methods of use are also disclosed.